Digital healthcare start-up EvoCare investors eligible for Federal INVEST grant!

Digital Treatment platform EvoCare attested eligible for Federal INVEST grant, rewarding private investors from the European Economic Area with a purchase grant worth 20% of their investment plus tax exemptions.

EvoCare, specialist in health care digitalization has been approved by the German Federal Ministry for Economic Affairs and Energy (BMWi) for their “INVEST – Venture Capital Grant”.

Founded in 2018, EvoCare is one of Germany’s pioneering digital health care services, working with hospitals, doctors and therapists across Germany and Austria.

The EvoCare platform is offering state-of-the-art digital treatment options – certified by Europe’s largest social security insurer Deutsche Rentenversicherung with almost 60 million insurants.

Doctors and therapists can create and broadcast their own therapeutical content; support patients in their homes either directly or via messaging system; can record and track remote treatment sessions; and use the EvoCare platform for managing patients, treatment and billing.

Approved for orthopedic treatment in 2019, EvoCare has a scientifically proven track-record, now aiming to extend its range of approved therapies to support patients with pulmonary, neurological, coronary and other conditions. Examples are Long Covid treatment, stroke rehabilitation, or physiotherapy.

With the INVEST grant private investors from the European Economic Area (EEA) will receive a 20% cash-back on their investment and allowances for capital gains tax during the investment period and on exit.

Effective November 25th, 2021, investments made until November 22nd, 2022 will be eligible for this.

About INVEST
INVEST is a federal program incentivizing private investors to support German start-ups.

Natural persons from the EEA (EU + Island, Liechtenstein and Norway) wanting to invest between €10,000 and €500,000 in young start-ups will receive a tax-free refund of 20% of the sum invested, retaining all of their shares in the company. On Exit – after at least three years - investors are not required to repay the grant. Any profits made are tax exempt up to 25% of the capital gain.

For more details on the INVEST program, please see
https://www.bmwi.de/Redaktion/EN/Publikationen/flyer-invest.pdf (PDF Download) and https://www.bmwi.de/Redaktion/EN/Pressemitteilungen/2020/20200702-altmaie-invest-gives-boost-to-venture-capital-market.html

Contact Germany
EvoCare Holding AG
Patricia Hein
Siemensstr. 3 b
D-90766 Fürth
Telefon: +49 911 32 38 00
https://digital-health.care

Contact Austria:
EvoCare GmbH
Rene Lehninger
Seilergasse 6
A-1010 Wien
Telefon: +43 1 533 79 39 14
https://evocare.at/

With more than 20 years of experience in health care digitalization, EvoCare® has developed systems and technologies to support patient treatment at home.

Pioneering digital health care, since 2018 the EvoCare Holding AG has opened new and innovative ways to medically treat patients in the comfort of their own home.

Independent of fixed time slots in clinics or practices, therapists can treat their patients and keep officially recognized records, allowing for reimbursements by the German statutory pension insurance (Deutsche Rentenversicherung).

Recently several private insurances have created “digital tariffs” including digital treatment methods like EvoCare® in their catalog of services covered. Streamlining treatment this way allows these cost bearers to save money by better utilizing resources right from the start.

EvoCare’s platform, unifies treatment, management and billing, relieving doctors, therapists and nurses while simultaneously ensuring verifiable therapy results.

More about EvoCare:
https://youtu.be/Tu72bWdTdQk

This release was published on openPR.